JCRB0066 Mewo
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0066 | Cell Name | Mewo |
---|---|---|---|
Profile | malignant melanoma | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 78 |
Identity | available | Tissue for Primary Cancer | melanoma, skin |
Case history | malignant melanoma | Metastasis | Y |
Tissue Metastasized | lymph node | Genetics | |
Life Span | infinite | Crisis PDL | |
Morphology | fibroblast-like | Character | Malignant melanoma (skin). Established from a melanotic lymph node metastasis. Slightly produces melanin. |
Classify | tumor | Established by | Bean,M.A. |
Registered by | Akiyama,M. | Regulation for Distribution | |
Comment | Year | 1985 | |
Medium | Eagle's minimum essential medium with non-essential amino acids and 10% fetal calf serum | Methods for Passages | Cells are treated with 0.02 % EDTA and 0.25 % trypsin. |
Cell Number on Passage | split ratio=1/8 | Race | |
CO2 Conc. | 5 % | Tissue Sampling | lymph node |
Tissue Type | malignant melanoma |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:2121721 | Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro. Kawashima I,Tada N,Fujimori T,Tai T J Biochem. 1990 Jul;108(1):109-15 |
Pubmed id:2736210 | Production of transforming growth factor-alpha in human tumour cell lines. Imanishi K,Yamaguchi K,Suzuki M,Honda S,Yanaihara N,Abe K Br J Cancer. 1989 May;59(5):761-5 |
Pubmed id:978138 | Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. Shiku H,Takahashi T,Oettgen HF J Exp Med. 1976 Oct 1;144(4):873-81 |
Research results by users. Click! | |
---|---|
Pubmed id:27595314 |
Stability and Bioavailability of Lentztrehaloses A, B, and C as Replacements for Trehalose. Wada S,Sawa R,Ohba S,Hayashi C,Umekita M,Shibuya Y,Iijima K,Iwanami F,Igarashi M J Agric Food Chem. 2016 Sep 28;64(38):7121-6 |
Pubmed id:2733038 |
Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. Cornil I,Man S,Fernandez B,Kerbel RS J Natl Cancer Inst. 1989 Jun 21;81(12):938-44 |
Images |
---|
LOT Information
Cell No. | JCRB0066 | Cell Name | |
---|---|---|---|
LOT No. | 04162002 | Lot Specification | distribution |
Medium | Eagle's minimal essential medium with non-essential amino acids and 10% fetal bovine serum | Temperature | 37 C |
Cell Density at Seeding | 6-9 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA in Ca, Mg-free PBS |
Doubling Time | D.T. = ca 44 hrs | Cell Number in Vial (cells/1ml) | 4.5 x 10^6 |
Viability at cell freezing (%) | 95 | Antibiotics Used | free |
Passage Number | P27 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD, LD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS-culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0066 | Cell Name | Mewo |
---|---|---|---|
LOT No. | 052493 | Lot Specification | distribution |
Medium | Eagle's minimal essential medium with Non-essential amino acids(GIBCO) and 10% FBS heat inactivated. | Temperature | 37 C |
Cell Density at Seeding | 1:8 dilution | Methods for Passages | Harvest cells by 0.02% EDTA and 0.2% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 3.2x10^6 |
Viability at cell freezing (%) | 97.4 | Antibiotics Used | free |
Passage Number | P24 | PDL | * |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Exoteric Gene | NT | |
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0066 | Cell Name | Mewo |
---|---|---|---|
LOT No. | 081391 | Lot Specification | distribution |
Medium | MEM w/ non essential amino acids + FCS 10% | Temperature | 37 C |
Cell Density at Seeding | dilution 1/8 | Methods for Passages | 0.02% EDTA and 0.25% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.2x10^6 |
Viability at cell freezing (%) | 95% | Antibiotics Used | free |
Passage Number | P24 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0066 | Cell Name | Mewo |
---|---|---|---|
LOT No. | 112789 | Lot Specification | distribution |
Medium | MEM w/ non essential amino acids + FCS 10% | Temperature | 37 |
Cell Density at Seeding | dilution 1/8 | Methods for Passages | 0.02% EDTA and 0.25% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 5.7x10^6 |
Viability at cell freezing (%) | NT | Antibiotics Used | free |
Passage Number | P24 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0066 | Cell Name | Mewo |
---|---|---|---|
LOT No. | 061587 | Lot Specification | distribution |
Medium | MEM w/ non essential amino acids + FCS 10% | Temperature | 37 |
Cell Density at Seeding | dilution 1/8 | Methods for Passages | 0.02% EDTA and 0.25% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 8x10^5 |
Viability at cell freezing (%) | 92% | Antibiotics Used | free |
Passage Number | P23 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | G6PD,LD,NP |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0066 | Cell Name | Mewo |
---|---|---|---|
LOT No. | 01122015 | Lot Specification | distribution |
Medium | Eagle's minimum essential medium with non-essential amino acids and 10% fetal bovine serum (FBS; GIBCO Cat. # 10091) | Temperature | 37 C |
Cell Density at Seeding | 1.5 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. Passage twice a week. |
Doubling Time | approx. 31 hrs | Cell Number in Vial (cells/1ml) | 1.5 x 10^6 |
Viability at cell freezing (%) | 83 | Antibiotics Used | free |
Passage Number | P26 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 83 | Additional information |